WALTHAM, Mass., Aug. 23, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a life sciences company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will host an interactive webcast, "Role of Galectin-3 in Therapeutic and Cardiovascular Outcomes – Results from Leading Studies Presented at the European Society of Cardiology Congress 2011." The webcast will be held on Tuesday, August 30, 2011, at 12:00 p.m. EDT (18:00 CEST), via CardiocareLive, a virtual cardiology congress produced by PlatformQ.
